Cognitive Decline, Glucose Variability
Conditions
Keywords
Brain-derived neurotrophic factor, Vascular cell adhesion molecule 1, Renalase, Orexin, Continue glucose monitor
Brief summary
To assess the effect of glucose monitors on glucose control and cardiovascular risks.
Detailed description
The investigators will enroll patients with diabetes. The answered questionnaire and blood samples will be collected at baseline. After change the methods or frequency of glucose monitor, the blood samples will be collected again. The investigators will analyze the factors which may affect the glucose control after changes in methods of glucose monitor.
Interventions
DEVICEContinue glucose monitor system
The cardiovascular risks and data from continue glucose monitor system
Sponsors
Taichung Veterans General Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adults with diabetes
Exclusion criteria
* Incooperative patients
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Glucose variability | 3 months | Data from continue glucose monitor system |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| brain-derived neurotrophic factor | 3 months | Biomarker of cognition |
| Orexin | 3 months | Biomarker of cognition |
| Renalase | 3 months | Biomarker of cognition |
| Vascular endothelial cell adhesion molecule 1 | 3 months | Biomarker for inflammation |
| Health Literacy | 3 months | Questionnaire of health |
Countries
Taiwan
Contacts
Primary ContactI-Te Lee, MD,PhD
Outcome results
None listed